COVID-19: blood thinners do not settle
In scientific studies, it has shown a close connection between the Coronavirus SARS-CoV-2-induced disease COVID-19, and coagulation disorders. In addition, it was found that many patients who are severely Ill thrombosis and pulmonary embolism. Experts underline the fact that heart patients should not stop your blood thinners.
A long time ago doctors made the observation that, in particular, in the case of serious COVID-19-disorders common to coagulation disorders. In addition, scientists at the University hospital Hamburg-Eppendorf (UKE) in the autopsies of COVID-19 deaths from pulmonary embolism as a common death, have found cause. Therefore, it is thinner on the importance of the intake of anticoagulants, the so-called “Blood”, pointed out.
Many are apprehensive at the moment extremely
According to a communication from the German heart Foundation piling in medical circles and the media reports about disturbances of the coagulation system in female patients and in patients with a COVID-19-disease.
Doctors see a connection between the coagulation disorders and severe gradients of the COVID-19-disease with complications such as deep vein thrombosis and pulmonary embolism and even death.
As the cause of this is excessive activation of the coagulation factors (“hypercoagulability”) and the blood platelets with an increased propensity to thrombus formation in the vessels is assumed.
“Patients, especially those with heart disease, which are associated with increased risk for embolism and infarction, and therefore permanently with Anticoagulants, the ,blood thinners’ are treated, are apprehensive at the moment are extreme,” says the cardiologist PD Dr. med. Gerian Grönefeld by the Scientific Advisory Board of the German heart Foundation.
Necessarily on DVT prophylaxis care
Millions of heart patients and patients requiring long term thrombosis prophylaxis with Anticoagulants such as oral anticoagulants (Marcumar/Falithrom, or the new DOAKs (Direct oral anticoagulants)).
This concerns, in particular cardiac patients with the most common heart rhythm disorder atrial fibrillation, and patients with an artificial heart valve. Even after a heart attack, Affected person must take their platelet inhibitors, such as ACE, Clopidogrel, and Prasugrel and Ticagrelor more reliably, and continuously.
“For these patients, there is no reason for concern, there is currently. Clinics, the Covid-19-provide patient care, are prepared, as a rule, such increased coagulation activity and activity-related medical precautions to reduce embolism risk,“ explains the chief physician of the I. Medical Department, cardiology at the Asklepios Klinik Barmbek.
With special attention to indoor and doctors, also with coagulation inhibitors associated bleeding risks are considered by the Medicine. “These patients with Anticoagulants should continue to pay attention to the consistent taking their medication for the thrombosis prophylaxis.”
At COVID-19-disease,: Treating on blood thinners-taking inform
In the case of an infection with the Coronavirus, patients should inform their treating Physicians about the existing thrombosis prophylaxis is essential to avoid an unwanted double-treatment with coagulation inhibitors.
Intensive care and emergency doctors demanded recently in a statement by the German society for Internal intensive care and emergency medicine (DGIIN), a DVT prophylaxis, and blood dilution, depending on the risk profile of the diseased Person – a stronger role in the treatment of COVID-19-Concerned need to play.
Vein thrombosis or pulmonary embolism in COVID-19-deceased
Experts estimate that about 20 percent of the COVID-19-Sick as a concomitant disease, severe coagulation disorders, with the consequence of venous thromboembolism have. Such vessel closures are at COVID-19-cases, occurred, which had a severe or lethal course of the disease.
The Vascular occlusion can lead to life-threatening complications such as heart attack, stroke, or pulmonary embolism. The reason for the frequent development of Thrombosis in COVID-19-patients and in -patients of Physicians, the suspect in an excessive coagulability of the blood, the Hyper-coagulation, the result of an inflammatory reaction in the Wake of the COVID-19-disease.
An Italian analysis of studies from China showed in laboratory values from COVID-19-patients and in -patients, an increase in the Protein, D-Dimer, which is formed when the blood vessels clot will have formed and the body’s own resolution of the blood clots arise.
In an autopsy study of Hamburg research Hamburg-Eppendorf (UKE) at the University hospital on the Basis of autopsies of COVID-19 of the deceased was found in the majority of cases, leg-vein thrombosis or pulmonary embolism.
“We could have had veins in the autopsy of the first 12 deceased to demonstrate that an unexpectedly high Rate of fatal pulmonary embolism stock, in addition, more than half of the patients with thrombosis of the leg,” explains Prof. Dr. Jan Sperhake, a senior physician in the Institute for legal medicine and first author of the study, said in a statement.
Healthy lifestyle in Corona times
The German heart Foundation indicates that, in Corona-times a healthy lifestyle with a healthy diet and, if possible, regular exercise for Heart patients is particularly important, in order to reduce the risk for a severe course of the disease.
The professionals recommend to be Concerned, therefore, Running or Cycling in the fresh air and Gymnastics at home, for example, with Exercises in workout videos from the Internet, from the sports club or the heart sports group.
The physical activity is not only good for the soul, but also helps to promote blood circulation and vascular elasticity, and to keep the heart fit. (ad)